Search research articles
Contact Us
Filters
Showing results (11-20 of 595) with videos related to
Page
of 60
Sort By:
Surgery Today
|
February 10, 2009
Abdominal septic aortic pseudoaneurysm caused by Campylobacter jejuni infection: report of a case
Jun-Neng Roan, Wen-Chien Ko, Chwan-Yau Luo
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 14, 2022
Geographic patterns of Acinetobacter baumannii and carbapenem resistance in the Asia-Pacific Region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2019
Yu-Lin Lee, Wen-Chien Ko, Po-Ren Hsueh
Frontiers in Medicine
|
June 17, 2022
Effects of Inappropriate Administration of Empirical Antibiotics on Mortality in Adults With Bacteraemia: Systematic Review and Meta-Analysis
Yuan-Pin Hung, Ching-Chi Lee, Wen-Chien Ko
Expert Opinion on Pharmacotherapy
|
March 14, 2013
Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections
Yen-Hsu Chen, Wen-Chien Ko, Po-Ren Hsueh
International Journal of Antimicrobial Agents
|
October 14, 2022
Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime/avibactam, meropenem/vaborbactam, and comparators against these isolates: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020
Yu-Lin Lee, Wen-Chien Ko, Po-Ren Hsueh
International Journal of Antimicrobial Agents
|
May 27, 2023
In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021
Yu-Lin Lee, Wen-Chien Ko, Po-Ren Hsueh
Frontiers in Pharmacology
|
October 23, 2019
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
Nan-Yao Lee, Wen-Chien Ko, Po-Ren Hsueh
Antibiotics (Basel, Switzerland)
|
November 27, 2021
Molnupiravir-A Novel Oral Anti-SARS-CoV-2 Agent
Ching-Chi Lee, Chih-Chia Hsieh, Wen-Chien Ko
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
October 16, 2021
Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?
Ching-Lung Lo, Ling-Shan Syue, Wen-Chien Ko
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
August 25, 2011
A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections
Chi-Jung Wu, Po-Ren Hsueh, Wen-Chien Ko
Page
of 60
Search research articles
Search
Showing results (11-20 of 595) with videos related to
Sort By:
Page
of 60
Surgery Today
|
February 10, 2009
Abdominal septic aortic pseudoaneurysm caused by Campylobacter jejuni infection: report of a case
Jun-Neng Roan, Wen-Chien Ko, Chwan-Yau Luo
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 14, 2022
Geographic patterns of Acinetobacter baumannii and carbapenem resistance in the Asia-Pacific Region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2019
Yu-Lin Lee, Wen-Chien Ko, Po-Ren Hsueh
Frontiers in Medicine
|
June 17, 2022
Effects of Inappropriate Administration of Empirical Antibiotics on Mortality in Adults With Bacteraemia: Systematic Review and Meta-Analysis
Yuan-Pin Hung, Ching-Chi Lee, Wen-Chien Ko
Expert Opinion on Pharmacotherapy
|
March 14, 2013
Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections
Yen-Hsu Chen, Wen-Chien Ko, Po-Ren Hsueh
International Journal of Antimicrobial Agents
|
October 14, 2022
Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime/avibactam, meropenem/vaborbactam, and comparators against these isolates: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020
Yu-Lin Lee, Wen-Chien Ko, Po-Ren Hsueh
International Journal of Antimicrobial Agents
|
May 27, 2023
In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021
Yu-Lin Lee, Wen-Chien Ko, Po-Ren Hsueh
Frontiers in Pharmacology
|
October 23, 2019
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
Nan-Yao Lee, Wen-Chien Ko, Po-Ren Hsueh
Antibiotics (Basel, Switzerland)
|
November 27, 2021
Molnupiravir-A Novel Oral Anti-SARS-CoV-2 Agent
Ching-Chi Lee, Chih-Chia Hsieh, Wen-Chien Ko
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
October 16, 2021
Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?
Ching-Lung Lo, Ling-Shan Syue, Wen-Chien Ko
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
August 25, 2011
A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections
Chi-Jung Wu, Po-Ren Hsueh, Wen-Chien Ko
Page
of 60